Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the...
29 insider purchases on record · latest filing 2021-06-28.
Insiders have also filed 13 sale transactions at TRVN.